Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice

被引:133
作者
Allers, C
Sierralta, WD
Neubauer, S
Rivera, F
Minguell, JJ
Conget, PA
机构
[1] Univ Chile, Programa Terapias Celulares, INTA, Santiago 11, Chile
[2] Univ Desarrollo, Fac Ciencias Salud, Santiago, Chile
[3] Clin Las Condes, Lab Med Nucl, Santiago, Chile
[4] Clin Las Condes, Lab Transplante Medula Osea, Santiago, Chile
关键词
mesenchymal stem cells; transplantation; biodistribution; homing; long-term engraftment;
D O I
10.1097/01.TP.0000128334.93343.B3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The use of mesenchymal stem cells (MSC) for cell therapy relies on their capacity to engraft and survive long term in the appropriate target tissue(s). Animal models have demonstrated that the syngeneic or xenogeneic transplantation of MSC results in donor engraftment into the bone marrow and other tissues of conditioned recipients. However, there are no reliable data showing the fate of human MSC infused into conditioned or unconditioned adult recipients. Methods. In the present study, the authors investigated, by using imaging, polymerase chain reaction (PCR), and in situ hybridization, the biodistribution of human bone marrow derived MSC after intravenous infusion into unconditioned adult nude mice. Results. As assessed by imaging (gamma camera), PCR, and in situ hybridization analysis, the authors' results demonstrate the presence of human MSC in bone marrow, spleen, and mesenchymal tissues of recipient mice. Conclusions. These results suggest that human MSC transplantation into unconditioned recipients represents an option for providing cellular therapy and avoids the complications associated with drugs or radiation conditioning.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 29 条
[1]   Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation [J].
Almeida-Porada, G ;
Porada, CD ;
Tran, N ;
Zanjani, ED .
BLOOD, 2000, 95 (11) :3620-3627
[2]   Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation [J].
Awaya, N ;
Rupert, K ;
Bryant, E ;
Torok-Storb, B .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (08) :937-942
[3]   Donor stem cells home to marrow efficiently and contribute to short- and long-term hematopoiesis after low-cell-dose unconditioned bone marrow transplantation [J].
Bubnic, SJ ;
Keating, A .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) :606-611
[4]  
CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
[5]   Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells [J].
Conget, PA ;
Minguell, JJ .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (04) :382-390
[6]  
Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO
[7]  
2-C
[8]   Cutting edge communication - Identification of a discrete population of human bone marrow-derived mesenchymal cells exhibiting properties of uncommitted progenitors [J].
Conget, PA ;
Allers, C ;
Minguell, JJ .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (06) :749-758
[9]   Mesenchymal stem cells: Biology and potential clinical uses [J].
Deans, RJ ;
Moseley, AB .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (08) :875-884
[10]   Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates [J].
Devine, SM ;
Cobbs, C ;
Jennings, M ;
Bartholomew, A ;
Hoffman, R .
BLOOD, 2003, 101 (08) :2999-3001